IN
InMed Pharmaceuticals Inc.
INM · NASDAQ
$1.39 -5.12% (-$0.08)
1M -11.11%
Market Cap $2.32M
P/E Ratio 0.00x
Div. Yield -
ROE 191.57%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/E 0.00x
P/B 0.00x
P/S 0.00x
Growth
100 /100
Growing Rev. growth 815.81%
Book val. growth 306.40%
EPS growth N/A
Profitability
53 /100
Moderate Gross margin 14.92%
FCF margin 341.77%
Net margin 25.83%
Quality
94 /100
Excellent ROIC 48.29%
Asset turnover 0.68x
ROE 191.57%
Debt
93 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -4.68x
Current ratio 1.37x
Stability
48 /100
Moderate Beta 0.98x
Profitable years 0
Rev. volatility 37,041.61%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o INM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Eric A. Adams Chem.
Employees
13
Headquarters
Vancouver
Prihajajoči dogodki
23 SEP.
Earnings
Upcoming earnings report
05 NOV.
Earnings
Upcoming earnings report